PMID: 3841366Aug 1, 1985Paper

The pharmacokinetics of alpha-methyldopa in dogs

Journal of Pharmacokinetics and Biopharmaceutics
G M Kochak, W D Mason

Abstract

alpha-Methyldopa was intraarterially and orally administered to dogs at two dose levels in a randomized complete crossover design. The appearance of secondary peaks in the plasma concentration-time profiles indicated the presence of enterohepatically recycled methyldopa. This was established by the absence of a secondary peak following readministration of a dose after biliary cannulation and the detection of methyldopa in the bile of a cannulated dog. Enterohepatic recirculation was estimated to account for a mean of 16.2% of the area under the plasma concentration-time profile after intraarterial administration. Total systemic clearance, defined as the sum of elimination by all routes from the general circulation of the administered dose, and corrected for enterohepatic recirculation, averaged (+/- SD) 99.4 +/- 24.6 ml/min in the dog. An extended average apparent terminal half-life of 6.0 +/- 5.2 hr was exhibited after oral administration compared to an average half-life of 3.1 +/- 1.8 hr following intraarterial administration. Elimination kinetics were linear in the dose range studied. Oral plasma concentration data suggest that the apparent bioavailable fraction may be dose dependent.

References

Apr 1, 1978·Journal of Pharmacokinetics and Biopharmaceutics·K YamaokaT Uno
Feb 1, 1979·Clinical Pharmacology and Therapeutics·J T Slattery, G Levy
Oct 14, 1977·European Journal of Clinical Pharmacology·O StenbaekT Hansen
Sep 1, 1976·Journal of Pharmaceutical Sciences·L I Harrison, M Gibaldi
Mar 1, 1970·Clinical Pharmacology and Therapeutics·R TabeiA Sjoerdsma
Apr 1, 1974·Journal of Pharmacokinetics and Biopharmaceutics·H G BoxenbaumR M Elashoff
Sep 1, 1973·Journal of Pharmaceutical Sciences·K C Kwan, A E Till
Apr 1, 1972·Scandinavian Journal of Clinical and Laboratory Investigation·E MyhreT Hansen
Apr 1, 1972·Scandinavian Journal of Clinical and Laboratory Investigation·E MyhreT Hansen
Jun 1, 1968·Journal of Pharmaceutical Sciences·J C Loo, S Riegelman
May 1, 1982·Clinical Pharmacokinetics·E MyhreT Hansen
Mar 3, 1962·JAMA : the Journal of the American Medical Association·P J CANNONJ H LARAGH
Oct 1, 1963·Circulation·A SJOERDSMAK ENGELMAN
May 1, 1962·The American Journal of Physiology·E C LINT H WILSON

❮ Previous
Next ❯

Citations

Apr 1, 1993·European Journal of Drug Metabolism and Pharmacokinetics·F Abi KhalilJ Dubois
May 21, 2010·Clinical Pharmacokinetics·Neal M DaviesJaime A Yáñez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.